We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.39%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$808M
AUM Growth
+$28.1M
Cap. Flow
-$73M
Cap. Flow %
-9.03%
Top 10 Hldgs %
19.87%
Holding
167
New
45
Increased
29
Reduced
50
Closed
37

Top Buys

Rank Stock Value
1
LSCC icon
Lattice Semiconductor
LSCC
+$13.2M
2
AZTA icon
Azenta
AZTA
+$11.7M
3
ASAN icon
Asana
ASAN
+$11.1M
4
FATE icon
Fate Therapeutics
FATE
+$9.15M
5
RVLV icon
Revolve Group
RVLV
+$8.52M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$15M
2
ALGT icon
Allegiant Air
ALGT
+$11.9M
3
HALO icon
Halozyme
HALO
+$11M
4
OSK icon
Oshkosh
OSK
+$10.4M
5
PCRX icon
Pacira BioSciences
PCRX
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.65%
2 Technology 26.22%
3 Industrials 16.12%
4 Consumer Discretionary 15.73%
5 Materials 2.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LTHM
26
DELISTED
Livent Corporation
LTHM
$8.89M 1.1%
459,430
+271,290
+144% +$4.93M
DDD icon
27
3D Systems Corp
DDD
$454M
$8.51M 1.05%
+212,885
New +$5.63M
LASR icon
28
nLIGHT
LASR
$4.01B
$8.5M 1.05%
234,174
-33,510
-13% -$1M
AXNX
29
DELISTED
Axonics, Inc. Common Stock
AXNX
$8.45M 1.05%
133,230
-1,895
-1% -$112K
MTDR icon
30
Matador Resources
MTDR
$6.1B
$8.44M 1.05%
234,410
-2,365
-1% -$68.9K
NUVA
31
DELISTED
NuVasive, Inc.
NUVA
$8.38M 1.04%
123,555
-108,715
-47% -$7.42M
EXTR icon
32
Extreme Networks
EXTR
$3.87B
$8.02M 0.99%
718,610
-7,270
-1% -$77.2K
RCKT icon
33
Rocket Pharmaceuticals
RCKT
$369M
$7.96M 0.99%
179,705
+27,287
+18% +$1.19M
CSTL icon
34
Castle Biosciences
CSTL
$919M
$7.89M 0.98%
107,650
+50,470
+88% +$3.33M
FRPT icon
35
Freshpet
FRPT
$2.93B
$7.77M 0.96%
47,669
-42,390
-47% -$7.23M
DNLI icon
36
Denali Therapeutics
DNLI
$3.66B
$7.7M 0.95%
+98,130
New +$6.07M
PRTS icon
37
CarParts.com
PRTS
$44.3M
$7.69M 0.95%
37,765
+28,469
+306% +$4.77M
BLMN icon
38
Bloomin' Brands
BLMN
$777M
$7.62M 0.94%
280,655
-236,710
-46% -$6.7M
TITN icon
39
Titan Machinery
TITN
$415M
$7.6M 0.94%
245,625
+76,015
+45% +$2.13M
APLS
40
DELISTED
Apellis Pharmaceuticals
APLS
$7.55M 0.93%
+119,445
New +$6.16M
SUM
41
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$7.45M 0.92%
217,475
-2,197
-1% -$69.3K
AMN icon
42
AMN Healthcare
AMN
$1.32B
$7.42M 0.92%
+76,470
New +$6.64M
NTRA icon
43
Natera
NTRA
$38.7B
$6.91M 0.86%
60,830
-69,213
-53% -$7.08M
GRWG icon
44
GrowGeneration
GRWG
$88.3M
$6.82M 0.85%
141,875
+44,590
+46% +$1.95M
ARWR icon
45
Arrowhead Research
ARWR
$11.8B
$6.77M 0.84%
+81,770
New +$6.09M
FIGS icon
46
FIGS
FIGS
$1.87B
$6.65M 0.82%
+132,725
New +$4.97M
MTZ icon
47
MasTec
MTZ
$20.5B
$6.64M 0.82%
62,605
-54,045
-46% -$5.87M
TBBK icon
48
The Bancorp
TBBK
$2.91B
$6.64M 0.82%
288,530
+8,015
+3% +$188K
UCTT
49
Ultra Clean Holdings
UCTT
$3.94B
$6.54M 0.81%
121,675
-34,640
-22% -$1.85M
NTNX icon
50
Nutanix
NTNX
$16.4B
$6.39M 0.79%
+167,320
New +$5.21M

Similar funds

Lisanti Capital Growth's Q2 2021 Portfolio in Review

As of Q2 2021, Lisanti Capital Growth held 167 positions worth $808M, up 3.6% from $779M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $73M in Q2 2021, closing 37 positions and reducing 50 holdings. Its most notable exit was Inspire Medical Systems, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Lattice Semiconductor worth $14.5M.

  • Lisanti Capital Growth's largest Q2 2021 buy was Lattice Semiconductor: 258,275 shares worth $14.5M.
  • Lisanti Capital Growth added most to Fate Therapeutics in Q2 2021, an estimated $9.15M increase.
  • Lisanti Capital Growth's biggest Q2 2021 reduction was Allegiant Air, cutting an estimated $11.9M.
  • Lisanti Capital Growth fully exited Inspire Medical Systems in Q2 2021, selling an estimated $15M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $808M portfolio in Q2 2021.
  • Lisanti Capital Growth opened 45 new positions and closed 37 in Q2 2021.
  • Lisanti Capital Growth's portfolio value rose 3.6% quarter-over-quarter to $808M.

Based on Lisanti Capital Growth's 13F filing for Q2 2021, filed 16 Aug 2021.